 Kenneth David Thompson
Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sinusitis | 9 | 2008 | 197 | 0.530 |
Why?
| | Pneumococcal Infections | 6 | 2008 | 45 | 0.400 |
Why?
| | Undaria | 1 | 2004 | 1 | 0.280 |
Why?
| | Phytotherapy | 1 | 2004 | 131 | 0.240 |
Why?
| | Plant Extracts | 1 | 2004 | 244 | 0.230 |
Why?
| | Rhinitis | 3 | 2008 | 156 | 0.210 |
Why?
| | Streptococcus pneumoniae | 5 | 2006 | 46 | 0.200 |
Why?
| | Antiviral Agents | 1 | 2004 | 489 | 0.200 |
Why?
| | Quinolines | 2 | 2006 | 90 | 0.150 |
Why?
| | Nasal Mucosa | 2 | 2006 | 183 | 0.140 |
Why?
| | Hypersensitivity | 2 | 2006 | 140 | 0.140 |
Why?
| | Ovalbumin | 3 | 2006 | 109 | 0.100 |
Why?
| | Anti-Bacterial Agents | 2 | 2006 | 700 | 0.100 |
Why?
| | Th1 Cells | 3 | 2006 | 163 | 0.100 |
Why?
| | Kaposi Varicelliform Eruption | 1 | 2008 | 6 | 0.090 |
Why?
| | Smallpox Vaccine | 1 | 2008 | 10 | 0.090 |
Why?
| | Ciprofloxacin | 1 | 2008 | 28 | 0.090 |
Why?
| | Paranasal Sinuses | 2 | 2006 | 58 | 0.090 |
Why?
| | Anti-Infective Agents | 1 | 2008 | 82 | 0.080 |
Why?
| | Th2 Cells | 2 | 2006 | 148 | 0.080 |
Why?
| | Respirovirus Infections | 1 | 2006 | 12 | 0.080 |
Why?
| | Leukotriene Antagonists | 1 | 2006 | 25 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2006 | 2179 | 0.080 |
Why?
| | Acetates | 1 | 2006 | 68 | 0.080 |
Why?
| | Aza Compounds | 1 | 2006 | 8 | 0.080 |
Why?
| | Azithromycin | 1 | 2006 | 13 | 0.080 |
Why?
| | Dexamethasone | 1 | 2008 | 305 | 0.080 |
Why?
| | Mupirocin | 1 | 2006 | 6 | 0.080 |
Why?
| | Hypersensitivity, Immediate | 1 | 2006 | 62 | 0.080 |
Why?
| | Conjunctiva | 1 | 2006 | 20 | 0.070 |
Why?
| | Gram-Positive Bacteria | 1 | 2006 | 19 | 0.070 |
Why?
| | Toll-Like Receptor 4 | 1 | 2005 | 89 | 0.070 |
Why?
| | Mice, Inbred C57BL | 6 | 2008 | 3054 | 0.070 |
Why?
| | Ascomycota | 1 | 2004 | 16 | 0.070 |
Why?
| | Epistaxis | 1 | 2004 | 19 | 0.070 |
Why?
| | Mycoses | 1 | 2004 | 43 | 0.070 |
Why?
| | Inhibitory Concentration 50 | 1 | 2004 | 59 | 0.070 |
Why?
| | Herpesvirus 2, Human | 1 | 2004 | 43 | 0.070 |
Why?
| | Microbial Sensitivity Tests | 1 | 2004 | 150 | 0.060 |
Why?
| | Acute Disease | 4 | 2006 | 802 | 0.060 |
Why?
| | Mice, Inbred BALB C | 4 | 2006 | 1038 | 0.060 |
Why?
| | Bacterial Infections | 1 | 2004 | 182 | 0.060 |
Why?
| | T-Lymphocytes | 2 | 2006 | 1194 | 0.060 |
Why?
| | Mice | 8 | 2008 | 10719 | 0.060 |
Why?
| | Pain | 1 | 2004 | 354 | 0.060 |
Why?
| | Herpesvirus 1, Human | 1 | 2004 | 242 | 0.050 |
Why?
| | Flow Cytometry | 3 | 2008 | 682 | 0.050 |
Why?
| | Colony Count, Microbial | 2 | 2008 | 47 | 0.040 |
Why?
| | Animals | 8 | 2008 | 25609 | 0.040 |
Why?
| | Adoptive Transfer | 2 | 2005 | 169 | 0.030 |
Why?
| | Female | 6 | 2008 | 42238 | 0.020 |
Why?
| | Isoindoles | 1 | 2008 | 13 | 0.020 |
Why?
| | Plasma | 1 | 2008 | 49 | 0.020 |
Why?
| | Administration, Topical | 1 | 2008 | 90 | 0.020 |
Why?
| | Dermatitis, Atopic | 1 | 2008 | 43 | 0.020 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2008 | 62 | 0.020 |
Why?
| | Immunoglobulin M | 1 | 2008 | 154 | 0.020 |
Why?
| | Family Health | 1 | 2008 | 160 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 74 | 0.020 |
Why?
| | DNA, Viral | 1 | 2008 | 268 | 0.020 |
Why?
| | Benzamides | 1 | 2008 | 219 | 0.020 |
Why?
| | Cytosine | 1 | 2008 | 121 | 0.020 |
Why?
| | Skin Transplantation | 1 | 2008 | 171 | 0.020 |
Why?
| | Nasal Lavage Fluid | 1 | 2006 | 26 | 0.020 |
Why?
| | Cyclopropanes | 1 | 2006 | 25 | 0.020 |
Why?
| | Sendai virus | 1 | 2006 | 8 | 0.020 |
Why?
| | Receptors, Interleukin-2 | 1 | 2006 | 66 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 2008 | 287 | 0.020 |
Why?
| | Nasal Provocation Tests | 1 | 2006 | 128 | 0.020 |
Why?
| | Fluoroquinolones | 1 | 2006 | 21 | 0.020 |
Why?
| | Histamine | 1 | 2006 | 128 | 0.020 |
Why?
| | Ointments | 1 | 2006 | 13 | 0.020 |
Why?
| | Sulfides | 1 | 2006 | 66 | 0.020 |
Why?
| | Nasal Cavity | 1 | 2006 | 91 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2008 | 443 | 0.020 |
Why?
| | Cataract Extraction | 1 | 2006 | 27 | 0.020 |
Why?
| | Genes, RAG-1 | 1 | 2005 | 13 | 0.020 |
Why?
| | Bacteriological Techniques | 1 | 2006 | 39 | 0.020 |
Why?
| | Glycolipids | 1 | 2005 | 36 | 0.020 |
Why?
| | Vitrectomy | 1 | 2006 | 48 | 0.020 |
Why?
| | Allergens | 1 | 2006 | 163 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2008 | 904 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2005 | 379 | 0.020 |
Why?
| | Humans | 4 | 2008 | 79536 | 0.020 |
Why?
| | Male | 4 | 2008 | 39423 | 0.020 |
Why?
| | Preoperative Care | 1 | 2006 | 386 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2005 | 400 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2005 | 514 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2006 | 1778 | 0.010 |
Why?
| | Inflammation | 1 | 2006 | 821 | 0.010 |
Why?
| | Child, Preschool | 1 | 2008 | 3544 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2005 | 718 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2005 | 1904 | 0.010 |
Why?
| | Prospective Studies | 1 | 2006 | 3870 | 0.010 |
Why?
| | Middle Aged | 2 | 2006 | 23950 | 0.010 |
Why?
| | United States | 1 | 2008 | 6050 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2006 | 6195 | 0.010 |
Why?
| | Aged | 1 | 2006 | 17397 | 0.010 |
Why?
| | Adult | 1 | 2006 | 24523 | 0.000 |
Why?
|
|
Thompson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Physical Neighbors People whose addresses are nearby this person. _
|